MENUNews Archive
Date: 08/31/2015
A new marker already linked to other types of cancer was found to play a role in retinoblastoma, a rare but lethal form of cancer. When advanced forms of RB affect both eyes, this cancer causes partial or full loss of vision in about 50 percent of patients. This tumor is normally treated by eye removal or administration of chemotherapy drugs that are often toxic to the normal retina, and thus can jeopardize vision. No targeted therapy, which selectively kills tumor cells but spares normal retinal cells, exists.
Date: 08/25/2015
Concerns about fertility kept a third of young women with breast cancer from taking tamoxifen, despite its known benefit in reducing the risk of breast cancer coming back.
Date: 08/07/2015
The information on this page has expired. Learn about pancreatic cancer treatment at research on our pancreatic cancer web pages.
Date: 07/29/2015
The University of Michigan Rogel Cancer Center’s Breast Oncology Program was one of nine beneficiaries of the 2014 QVC Presents "FFANY Shoes on Sale" event. FFANY and QVC representatives presented a check for $380,000 to the Rogel Cancer Center.
Date: 06/23/2015
Cancerous tumors cast off tiny telltale genetic molecules known as microRNAs and a team of University of Michigan researchers has come up with an efficient way to detect them in blood.
Date: 06/19/2015
President Barack Obama announced his selection of Max S. Wicha, M.D., as one of five new appointees to the National Cancer Advisory Board.
Date: 06/10/2015
A new study suggests that fusion of one normal cell with another — as observed in inflammation, infection, and injury from carcinogens — triggers a “genomic catastrophe” that converts normal cells to cancer cells and enables tumors to form.
Date: 06/02/2015
A survey of women with breast cancer found that nearly half considered having a double mastectomy. But of those who considered it, only 37 percent knew that the more aggressive procedure does not improve survival for women with breast cancer.